The Cooper Companies, Inc. (LON:0I3I)
68.34
+0.94 (1.40%)
At close: Sep 5, 2025
Revenue by Product
Fiscal year is November - October.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2013 - 2019 |
Toric Lens | - | Log In | Log In | Log In | Log In | Upgrade |
Toric Lens Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Multifocal Lens | - | Log In | Log In | Log In | Log In | Upgrade |
Multifocal Lens Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Single-Use Sphere Lens | - | Log In | Log In | Log In | Log In | Upgrade |
Single-Use Sphere Lens Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Non Single-Use Sphere Lens and Other | - | Log In | Log In | Log In | Log In | Upgrade |
Non Single-Use Sphere Lens and Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Office and Surgical Products | 774.70M | Log In | Log In | Log In | Log In | Upgrade |
Office and Surgical Products Growth | 7.62% | Log In | Log In | Log In | Log In | Upgrade |
Fertility | 511.30M | Log In | Log In | Log In | Log In | Upgrade |
Fertility Growth | 5.98% | Log In | Log In | Log In | Log In | Upgrade |
Toric and Multifocal | 1.26B | Log In | Log In | Log In | Log In | Upgrade |
Sphere, Other | 1.35B | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is November - October.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2013 - 2019 |
Other | 2.20M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
CooperVision Operating Income | 676.20M | Log In | Log In | Log In | Log In | Upgrade |
CooperVision Operating Income Growth | 21.69% | Log In | Log In | Log In | Log In | Upgrade |
CooperSurgical Operating Income | 118.30M | Log In | Log In | Log In | Log In | Upgrade |
CooperSurgical Operating Income Growth | -30.77% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Operating Income | -88.80M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Operating Income Growth | 7.26% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.20M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is November - October.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2013 - 2019 |
United States | 1.97B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | -6.70% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 1.16B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 5.65% | Log In | Log In | Log In | Log In | Upgrade |
Rest Of The World | 773.60M | Log In | Log In | Log In | Log In | Upgrade |
Rest Of The World Growth | -4.46% | Log In | Log In | Log In | Log In | Upgrade |